Intervention

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions11

Lead sponsors shown3

Clinical trials

3 shown

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseNCT07058155 · 2025-12-17

RECRUITING

Achieving Portal Access With Scorpion Post-Approval Study (APASS)NCT05765253 · 2023-07-13

TERMINATED

Decompression Intervention of Variceal Rebleeding Trial (DIVERT)NCT00006161 · 1996-12-01

COMPLETED

Common conditions

Ascites Hepatic1 Esophageal and Gastric Varices1 Hydrothorax1 Liver Cirrhoses1 Liver Cirrhosis1 Liver Diseases1 Portal Hypertension1 Portal Hypertension Related to Cirrhosis1 Severe Obesity1 TIPS1 Vascular Diseases1

Leading sponsors

Argon Medical Devices 1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1 The Cleveland Clinic 1

Trial status mix

COMPLETED1

RECRUITING1

TERMINATED1

Phase mix

NA1

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.